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highlights the many events that have taken place in the 
first quarter of 2018. 
Our section on “Our People, Our Story” features Professor 
Dr. Christina Tan Phoay Lay and Professor Dr. Maznah 
Dahlui who delivered their inaugural lecture in January 
and March, respectively. Both spoke passionately about 
their experiences and achievements. 
We are very proud of Professor Dr. Ng Kwan Hoong, 
Department of Biomedical Imaging, for being the first 
Asian scientist to be honoured with the highest rank 
and the most prestigious award in Medical Physics – 
the Marie Sklodowska-Curie Award bestowed by the 
United Kingdom-based International Organization for 
Medical Physics (IOMP).
I’d like to also congratulate the Clinical Investigation 
Centre (CIC), UMMC, for recently being ranked 7th in the 
Top-10 IQVIA Prime Sites globally. IQVIA is the world’s 
largest contract research organisation (CRO) for 
clinical research, and this is quite an achievement
This issue of Pulse@UM also serves you with news on 
various research facilities, initiatives and activities 
within the faculty. Many may not be aware that our 
Faculty has one of the leading research teams on snake 
venom. To entice you to this topic, we have an article 
called “From Genes to Fangs”. 
Lastly, we rejoice with the various award recipients and 
the recognition received by Faculty colleagues and the 
Silent Mentor Centre, UM. At the rate we are going, I am 
sure that the 365 page book that we are writing, will be 
an eventful one.
Keep up the good work!
With best wishes,
 
Professor Dr Yvonne Lim Ai Lian
My warmest greetings to all! 
At the beginning of the year, I came 
across a quote that said “Today, is 
the first blank page of a 365 page 
book, so write a good one.” The year 
has certainly drifted by very quickly 
and this 2nd issue of Pulse@UM 
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MESSAGE FROM 
DEPUTY DEAN 
(RESEARCH)
PROFESSOR DR. 
CHRISTINA TAN PHOAY LAY: 
OUR BELOVED FAMILY MEDICINE SPECIALIST, 
MEDICAL EDUCATOR AND LIFE-LONG LEARNER
TAN KAE YI
DEPARTMENT OF MOLECULAR MEDICINE
of Objective Structured Clinical Examination 
(OSCE) at the University of Chicago, and on their 
return they embarked on developing our OSCEs 
from scratch. OSCE was then introduced as a 
component of the final examinations of the 
undergraduate medical programme (the New 
Integrated Curriculum, which started in 1998), and 
the first stationed-OSCE was conducted 
successfully in 2003.
   With her deepening interest in medical 
education, she received a medical education 
fellowship with the U.S.-based Foundation for the 
Advancement of International Medical Education 
and Research (FAIMER) in 2005-2006. This was a 
life-changing experience providing her an 
opportunity to network internationally with health 
professions educators. Her interest in medical 
education led to further pursuit of postgraduate 
qualifications in health professions education 
culminating in a doctorate. 
   The elements that have contributed to 
Professor Tan’s self-motivation or desire to learn 
include the passion to get the best out of her 
students, wanting to have a sound and fair 
assessment for them,  and having the strength and 
resilience to pursue further training for better 
patient care. Lastly, she shared with us this 
take-home message: “Learning how to reflect is a 
ﬁnal important ingredient in this recipe for lifelong 
learning”.
“Learning how to reflect 
is a ﬁnal important 
ingredient in this recipe 
for lifelong learning”.
- Professor Christina Tan
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OUR PEOPLE
OUR STORY 
   A family medicine specialist, a medical 
educator and a life-long learner, these are the 
various roles that Professor Dr. Christina Tan 
Phoay Lay are always remembered of in the hearts 
of her colleagues and students. Professor Tan was 
originated from Georgetown, and obtained her 
medical training at the London Hospital Medical 
College in Whitechapel, United Kingdom.
   Professor Tan started her service at the 
Faculty of Medicine and the University Hospital as 
a medical lecturer in the Department of Primary 
Care Medicine. Throughout her academic career, 
she has always exhibited additional outstanding 
quality as a medical educator. Back then, teaching 
expertise was assumed to be part of content 
expertise. “These early learning experiences as a 
lecturer demonstrate to me a need for teachers to 
learn how to teach first,” she said. Along the way, 
she noticed that the old-fashion “teacher-centred” 
teaching has been gradually replaced by a more 
“student-centred” learning. Thus, she took initiative 
to “re-learn” as a student and learn on the desire to 
provide optimum’s care. In a special opportunity, 
she was awarded an International Fellowship in 
Medical Education by the U.S.-based Education 
Commission for Foreign Medical Graduates in 
2000 that allowed her to spend 6 months at the 
University of New Mexico (UNM) in al Albuquerque, 
New Mexico, which was well known in 
problem-based learning (PBL) circles. On her 
return, she pioneered the implementation of PBL in 
the undergraduate medical curriculum in UM with 
Professor Dr. Nor Azila Mohd Adnan and Professor 
Dr. Debra Sim Si Mui, who were equally 
enthusiastic about medical education. Since then, 
PBL gained more support and continued to 
blossom in today’s new curriculum of the 
University of Malaya Medical Programme (UMMP). 
   Another factor that has been a driver in her 
desire to learn is to do with assessment. Teaching 
and learning go hand in hand with assessment. 
Together with the late Professor Dr. Rokiah Pendek, 
they were trained for the preparation and conduct  
PROFESSOR DR. MAZNAH DAHLUI:
“WOMEN’S EMPOWERMENT: ECONOMIC EVALUATION FOR HEALTH ADVOCACY AND 
INFORMED POLICY”
TAN KAE YI
DEPARTMENT OF MOLECULAR MEDICINE
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   Renowned Professor of Health Economics Dr. Maznah Dahlui was the featured guest for an inaugural 
lecture on 15th March 2018. Professor Dr. Maznah is a Public Health Medicine Specialist at the forefront of 
serving the Ministry of Health (MOH), Malaysia. She joined University of Malaya in the year 2003. Her 
specialty is health economics, with a major interest in the economic evaluation of health programs. 
Throughout her career, she conducted many economic evaluations on the country’s health policies and 
programs, working closely with various ministries in Malaysia. She also has good linkages with international 
institutions such as the UNFPA, UNESCO, World Bank and WHO, which have led to several consultancy 
projects centred on the evaluation and monitoring of health programs.
   In 2005, the first and most remarkable economic evaluation in her life was conducted for her Ph.D. 
study. A health intervention to ask for a more cost-effective measure was proposed to the MOH in order to 
subsidize Desferrioxamine (an iron chelator drug which at that time was expensive for 
Transfusion-Dependent Thalassemia Patients (TDTP). After an economic evaluation, the MOH finally 
decided to consider the findings to justify the listing of the drug in the Blue book. Since then, 
Desferrioxamine has been available for free for TDTP at all government hospitals. 
   With economic evaluation increasingly becoming a tool for advocacy in health care programmes, it can 
help make informed decisions concerning the efficiency and allocation of resources in the implementation 
of strategies. It is used to advise care providers and patients on the best available research evidence to 
enhance their practices. Reasons for employing economic evaluation in health care decision-making are (i) 
maximisation of benefits from health care spending; (ii) overcoming regional variations in access; (iii) 
containing costs and managing demand; and (iv) providing bargaining power when dealing with suppliers of 
healthcare products. With current global needs, her research interest extends to cancer screening, infectious 
diseases such as HIV and Hepatitis C, health issues of adolescents, and obesity prevention, in which 
economic evaluations are necessary to improve efficiency of service provision or to measure the value of 
money utilised on health intervention programs.
   Professor Dr. Maznah has been actively engaging NGOs (such as the Breast Cancer Welfare Society 
and MAKNA) and communities (the urban poor community and rural populations). International research 
collaborations have also been initiated with many well-known institutions including the Sanger Institute 
(University of Cambridge, United Kingdom), Kirby Institute (University of New South Wales, Australia), 
University of Usmanu Danfodia (Sokoto, Nigeria), and several others. Upon her success, Professor Dr. 
Maznah was appointed as the Regional Director of the Asia-Pacific Academic Consortium for Public Health 
(APACPH) in 2013. On top of that, the APACPH Secretariat was successfully relocated to the University of 
Malaya in 2012 with her holding the post of Secretary until today. That allows her to initiate research 
collaborations on community obesity prevention with several of the 87 APACPH member institutions. 
   Her outstanding contributions to public health in such a short span of time contributed significantly to 
her appointment as the Chair for both “National Clearinghouse for Adolescent Health” and “Technical 
Advisory Committee of Health Technology Economic Evaluation (TACHTEE)” in Malaysia, as a Fellow of the 
Public Health Medicine Specialists Association, Malaysia and Distinguished Fellow of the Faculty of Public 
Health, Royal College of Physicians in the UK.  She demonstrated strong leadership capabilities when she 
was chosen as the head of Department of Social & Preventive Medicine (2011-2016) and Deputy Dean 
(Infrastructure & Development) of the Faculty of Medicine in 2016.
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FIRST MEDICAL PHYSICIST FROM A DEVELOPING COUNTRY TO RECEIVE THE MARIE 
SKLODOWSKA-CURIE AWARD FROM THE INTERNATIONAL ORGANIZATION FOR 
MEDICAL PHYSICS
FADZILAH HANUM MOHD MYDIN 
DEPARTMENT OF PRIMARY CARE MEDICINE
profession in this region of the world. Receiving 
this international recognition is very meaningful 
for him and others in the medical physics field in 
Malaysia. Prior to this, in 2013, Professor Ng was 
also named one of IOMP’s top 50 medical 
physicists in the world.
   His pre-eminent achievement in expanding 
the medical physics field in this nation was the 
establishment of the University of Malaya Medical 
Physics Master’s program two decades ago. It is 
the only post-graduate medical physics academic 
program outside the United Kingdom and Ireland 
accredited by the UK Institute of Physics and 
Engineering in Medicine. This program has 
produced many medical physicists throughout the 
country and internationally. He has also been 
actively teaching and training radiologists and 
clinical oncologists for over two decades. Another 
excellent contribution Prof Ng made towards the 
progress of medical physics is the establishment 
of the ASEAN College of Medical Physics in the 
year 2014.
   Looking back at his career progress earlier, 
he was among the pioneers of radiation medicine 
during the early years of his career as an educator 
and researcher. He also been serving as a 
consultant and expert for the International Atomic 
Energy Agency (IAEA);  and Fukushima Daiichi 
Accident Report (2015).
   He is also the founding president and 
president emeritus of the South-East Asian 
Federation of Organizations for Medical Physics, 
and co-founder and past-president of the 
Asia-Oceania Federation of Organizations for 
Medical Physics. In addition to being a Fellow of 
the Academy of Science Malaysia, he is also one of 
the very few non-clinicians to be inducted into the 
Academy of Medicine Malaysia. 
OUR PEOPLE OUR STORY 
   Professor Dr Ng Kwan Hoong is the first 
scientist from a developing country to be honoured 
to receive the highest rank and the most 
prestigious award in Medical Physics – the Marie 
Sklodowska-Curie Award bestowed by the United 
Kingdom-based International Organization for 
Medical Physics (IOMP), which represents 25,000 
medical physicists worldwide. Medical physics 
deals with the application of physics and 
engineering in medicine. Professor Ng will be 
receiving the award during the World Congress on 
Medical Physics and Biomedical Engineering that 
will be held in Prague this coming June.
 
   He has made significant contributions to 
breast cancer research and is determined to 
improve early cancer detection and achieve more 
reliable prediction of cancer risk. He has been 
leading several international collaborative projects, 
one of which is with fellow researchers in 
Singapore to use artificial intelligence techniques 
in improving the accuracy of diagnosis. He has 
also published extensively in radiation dosimetry, 
digital imaging and risk communication. This 
award, given once in three years, honours medical 
physicists who have contributed to the education 
and training of medical physicists, medical 
residents, medical students and health personnel; 
achieved excellence in biomedical research; and 
contributed to the advancement of the profession.
   Some of the past eminent recipients of this 
award include: Prof. John R Cameron from the 
United State of America (USA) (2000), the inventor 
of the bone mineral densitometer (for detection of 
osteoporosis); Prof. Charles Mistretta from USA 
(2012), the inventor of digital subtraction 
angiography (the basis for cardiac angiography, 
interventional procedures); and Prof. Colin Orton, 
USA (2015) who also applied novel radiobiology 
concepts in radiotherapy. 
   He acknowledges this recognition as 
phenomenal because it shows that scientists from 
developing nations like Malaysia can also 
contribute to the well-being of humanity. Besides 
that, medical physics is a novel field and 
BRIDGING HEALTH AND ICT TO 
IMPROVE HEALTHCARE: THE 
UNIVERSITY OF MALAYA EHEALTH 
INITIATIVE (UMEHI)
NG CHIRK JENN & TEO CHIN HAI 
DEPARTMENT OF PRIMARY CARE MEDICINE
CONNECT
THE WORLD
   The University of Malaya eHealth Initiative 
(UMeHI) was established in April 2017 and is 
hosted under the Faculty of Medicine, with the 
Faculty of Computer Science and Information 
Technology (FCSIT) as its key partner. The UMeHI 
aims to use information and communications 
technology (ICT) to improve healthcare for patients 
and the community. The UMeHI team, comprising 
researchers, healthcare professionals, computer 
scientists and industry representatives, aims to 
work together to provide effective, sustainable and 
innovative solutions to address real world 
healthcare challenges. 
   The Initiative targets three domains: 
Research, Education and Clinical Services. Under 
the Research track, the UMeHI conducts 
bi-monthly journal clubs to update researchers on 
current eHealth trends and share ideas. The UMeHI 
also conducts regular workshops to train 
researchers in eHealth, such as using software to 
analyse big data involving machine learning 
(artificial intelligence).
 
  
   The Education track focuses on using ICT to   
deliver accessible and effective training for 
medical students, postgraduate trainees, and 
healthcare professionals. In February 2018, the 
UMeHI conducted a workshop on ‘Design and 
implementation of effective technology-enhanced 
learning solutions for medical education’ which 
was led by Associate Professor Dr Sunhea Choi, an 
instructional design expert from the University of 
Southampton. 
   The third aim of the UMeHI is to improve 
clinical service delivery using ICT. The UMeHI 
works closely with the University of Malaya 
Medical Centre’s (UMMC) IT Department to create 
a research data management system to support 
research and improve patient care using the 
electronic medical record (EMR) system. 
Additionally, the UMeHI is also developing other 
tools to enhance clinical service delivery. For 
instance, a pre-consultation patient agenda 
system and an evidence retrieval system have 
been developed to facilitate doctors in finding out 
their patient’s agenda, and to empower clinicians 
to practise evidence-based medicine. 
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The UMeHI is honoured to host the FOM Research 
Carnival 2018 on 15-19 October 2018. We hope to 
increase awareness within the communities of 
FOM and UMMC as well as the public on the 
potential uses of ICT to improve healthcare 
through innovation. International eHealth experts 
will be invited and interesting activities such as a 
hackathon will be organised during the eHealth 
Research Festival. So do join us! 
The UMeHI is a one-stop centre that shares 
resources and expertise on eHealth with the main 
goal of improving patient care. The UMeHI 
welcomes collaboration across all institutions and 
disciplines to conduct research, enhance teaching 
and learning, and innovate healthcare delivery 
through eHealth.
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Medical Parasitology: A Textbook is the fruit of many years of 
experience in teaching medical students in the field of 
parasitology. The study of parasitology is daunting to the 
uninitiated. This book aims to promote an easy yet 
comprehensive way of learning this subject. It attempts to 
simplify the complexity of medical parasitology into parts that 
are easy to understand, integrating the essential information of 
parasitic infections. This integration of knowledge will be 
achieved through reader-friendly illustrations, inclusion of a 
collection of case reports, samples of test questions and the 
images of human parasites. Essentially, the book provides a 
“one-stop learning package” for medical parasitology.
Author: 
Rohela Mahmud, Yvonne Lim Ai Lian, Amirah Amir
Publisher: Springer
ISBN (eBook): 978-3-319-68795-7
Author: 
Sajaratulnisah Othman, Fadzilah Hanum Mohd 
Mydin, Sharifah Norsuhaida, Farizah Mohd Hairi, 
Noran Naqiah Hairi, Choo Wan Yuen
Publisher: University of Malaya
ISBN (eBook): 978-3-319-68795-7
Abuse and neglect of older person is an emerging problem in 
Malaysian society in view of the ageing population. Primary 
care physicians strategically located in the community have an 
important role to intervene in elder abuse and neglect. The 
Prevent Elder Abuse Initiative (PEACE) team has successfully 
produced a manual to support primary care physicians in 
identifying and managing elder abuse and neglect. Important 
aspects that are highlighted in the manual include the 
introduction of the SASO Model (S for ‘having high suspicion of 
abuse and neglect’, A for ‘assess holistically’; S for ‘ensure 
safety’ and O for ‘discuss available options’) and a workflow of 
possible clinical actions to be taken when facing with different 
situations at primary care level. It is hoped that the manual will 
become an important guide for primary care physicians in 
supporting older patients in the community.
CLINICAL INVESTIGATION CENTRE (CIC):
A WORLD-LEADING PRIME SITE FOR CLINICAL 
TRIALS IN MALAYSIA
HASNIZA ZAMAN HURI
CLINICAL INVESTIGATION CENTRE (CIC)
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RESEARCH 
SPORTLIGHT 
CIC’s TEAM
I
“Being recognised by IQVIA is an important milestone for us as 
we continue to manage and conduct more and more clinical trials 
at UMMC. The capabilities of our distinguished scientists, 
researchers, study teams, processes, and upgraded facilities give 
us the opportunity to work with some of the world’s biggest and 
most notable companies. With continuous support from 
everyone, our international story will continue to grow”. 
- Assoc Prof Dr Hasniza Zaman Huri, Director of CIC
   The UM Clinical Investigation Centre (CIC) was recently ranked 3rd among the Top-5 IQVIA APAC Prime 
Sites and 7th in the Top-10 IQVIA Prime Sites globally. IQVIA is the world’s largest contract research 
organisation (CRO) for clinical research. CIC was named the first prime site in Asia by IQVIA in the year 2010. 
Since then, we have strived hard to keep our scores high and have successfully renewed this recognition for 
the 7th consecutive year in 2017.  
   CIC was recognised as the first centre in Malaysia for the INSPIRE Site Program by Pfizer Inc, the 
world’s largest research-based pharmaceutical company, in July 2013. This prestigious status was 
successfully renewed in 2018. INSPIRE – which stands for Investigator Networks, Site Partnerships and 
Infrastructure for 
Research Excellence – is a strategic set of sites that are highly productive, medically relevant, and aligned 
to Pfizer’s business.   In 2016, CIC was named as the first Alliance Partner in Malaysia for PAREXEL, the 
second largest CRO in the world. In response to this success, the manager of CIC, Miss Krisna Veni 
Balakrishnan said, “None of this would have been possible without the support from the whole team. Our 
most important resource is not our money, it is our soul – which is made up of our people who strive hard to 
ensure the success of CIC. For all these glorious achievements, CIC would like to take this opportunity to 
express its utmost gratitude to the University Malaya Medical Centre, University of Malaya, investigators, 
researchers, study coordinators, sponsors, contract research organizations and everybody who has played 
a role in transforming CIC into a world-renowned centre for clinical investigation”.
Dr Tan Jiunn Liang is examining his patient
AWARDS & RECOGNITIONS
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Professor Dr Jamunarani S Vadivelu receives fellowship from Royal College of Pathologists 
Professor Dr Jamunarani S Vadivelu from the Department of Microbiology received her FRCPath from the 
Royal College of Pathologists recently.
Appointment as Member of WHO Technical Working Group: Package of Priority 
Rehabilitation Intervention
Associate Professor Dr Nazirah Hasnan, Department of Rehabilitation Medicine, Faculty of Medicine has 
been appointed as a member of the WHO Technical Working Group: Package of Priority Rehabilitation 
Intervention. Currently, she is the Deputy Director (Clinical) of the University of Malaya Medical Centre.
Appointment as Review Advisor of WHO Working Group on Snakebite Envenoming
Professor Tan Nget Hong from the Department of Molecular Medicine as a Review Advisor of the WHO 
Working Group on Snakebite Envenoming. This is a wonderful international recognition of the tremendous 
work that he and his team have done in this area.
Silent Mentor Centre (SMC) of UM recognised for its selfless service - The 4th Tan Kah Kee 
Award
The Silent Mentor Centre (SMC) of UM was awarded the 4th Tan Kah Kee Award for its contribution towards 
education/ public service.  The Tan Kah Kee Award was established in 2014 with the aim of encouraging and 
fostering the selfless contributions of individuals and organizations.  This is a well-deserved recognition for 
our academic staff who have passionately taught and inspired medical students throughout the program to 
become compassionate doctors.
Affiliate of the Young Scientists Network - Academy of Sciences Malaysia (YSN-ASM)
Dr Tan Choo Hock from the Department of Pharmacology has been appointed as an affiliate to the Young 
Scientists Network - Academy of Sciences Malaysia (YSN-ASM) for a period of three years (until 2021).
   Apart from all these achievements CIC has 
also successfully shifted into new premises which 
are located in the East Tower of UMMC. This is to 
accommodate the needs of our users and to meet 
national and international requirements in order to 
undertake and conduct clinical trials from Phase I 
to Phase IV. CIC (Clinical) is well equipped with 
modern and advanced equipment and facilities for 
the purpose of conducting clinical trials.  Sheer 
hard work and dedication to delivering excellent 
value and service to patients, clients, partners, and 
customers have rewarded CIC today with many 
achievements and recognitions, and we hope that 
success continues to follow us for years to come. 
RESEARCH SPOTLIGHT
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TROPICAL INFECTIOUS DISEASES RESEARCH AND EDUCATION CENTRE 
THE LEADING ONE-STOP RESEARCH AND EDUCATION CENTRE 
FOR TROPICAL INFECTIOUS DISEASES IN MALAYSIA
KHOO JING JING, MORVARID AKHAVAN REZAEI, 
MOHD ISKANDAR JEFREE BIN JOHARI, JURAINA 
BINTI ABD. JAMIL & SAZALY BIN ABU BAKAR 
TROPICAL INFECTIOUS DISEASES 
RESEARCH & EDUCATION CENTRE
TIDREC
RESEARCH SPOTLIGHT
The Tropical Infectious Diseases Research and Education Centre (TIDREC) was established in 2008 by the 
University of Malaya as a one-stop research and education centre for the advancement of knowledge in the 
field of tropical infectious diseases. Currently, TIDREC is a UM Centre of Excellence (UMCoE), with ongoing 
collaboration with both local and international partners in research projects with potential global impact. 
The Centre houses the WHO Collaborating Centre for Arbovirus Reference and Research and has been 
leading research in dengue and other arthropod-borne diseases in Malaysia and the region for the past 
decade. Some of TIDREC’s recent notable activities include:
INDUSTRY AND STAKEHOLDER ENGAGEMENT: VACCINE AND PROTEIN THERAPEUTICS PROCESS 
DEVELOPMENT (VAKSIN) LUNCHEON TALK
On 30 January 2018, TIDREC successfully organized the VAKSIN Luncheon Talk which gathered officials 
from institutional partners Baylor College of Medicine (BCM-TCH); Texas Children’s Hospital Centre for 
Vaccine Development, USA; Malaysian government ministries and national regulators; the Ministry of Health 
and National Pharmaceutical Regulatory Agencies (NPRA); as well as various government and industry 
RESEARCH SPOTLIGHT
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VIJAYAPANDI PANDY
DEPARTMENT OF PHARMACOLOGY
   Common it is to see laboratory animals 
being tested for drug-induced activities on 
diseases like cancer, diabetes and hypertension. 
Relatively uncommon is animal experimentation 
that incorporates behavioral techniques in the 
study of neuropharmacology. This is a maturing 
science in medicine that contributes to our deeper 
understanding of drug-behaviour interactions. In 
the Faculty of Medicine, the Behavioural 
Pharmacology Research Group headed by Assoc. 
Prof Dr. Vijayapandi Pandy is no less appreciated 
for their achievements in this niche research area.
   The group’s primary interest has been on 
neuropsychopharmacological evaluation of 
psychoactive natural products  for potential 
clinical effectiveness. This is in line with drug 
discovery for improved treatment of 
neuropsychiatric diseases such as depression, 
anxiety, psychosis, alcohol dependence and drug 
addiction, which are illnesses on the rise in today’s 
world. The group has been working actively on 
testing the effect and mechanisms of action of the 
many neuropharmacological agents and 
behaviourally active compounds as well as drugs.
 
ANIMAL EXPERIMENTATION 
ON DRUGS AND BRAINS
RESEARCH SPOTLIGHT
   At present, this group is working on medicinal plants like Morinda citrifolia, Acorus calamus and 
Mitragyna speciosa. Some of their findings include discoveries of the central receptor systems involved in 
anxiolytic- and antidepressant-like activities of Morinda citrifolia (noni) fruit extract, and the efficacy as well 
as mechanism of a compound from Acorus calamus (sweet flag) that works against depression-like 
symptoms in nicotine withdrawal. 
   The group has also reported antipsychotic-like activity of noni fruit in animal models for the first time. 
It is exciting to know that this part of the work will move from bench to bedside whereby the antipsychotic 
activity of M. citrifolia fruit may soon be tested in psychiatric patients in collaboration with King’s College of 
London. Similarly, the anticraving property of M. citrifolia fruit against heroin, alcohol and methamphetamine 
dependence has been established in animal models. These findings also be extended to clinical research to 
treat various kinds of drug addiction. Moreover, the group constantly works to develop and refine behavioural 
techniques for drug screening and evaluation. One of their innovative products was the development of a 
new prototype mouse model for drug self administration.
   Associate Professor Dr Pandy and his team’s research was supported by various research grants such 
as BKP, PPP, UMRG and HIR-MOHE. He also received an International award - “Mahatma Gandhi Samman” - 
for his excellent contribution to the field by the NRI Welfare Society in Bangkok, Thailand on 27 May, 2017. 
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TAN CHOO HOCK
DEPARTMENT OF PHARMACOLOGY
FROM GENES TO FANGS: 
UNRAVELING THE SECRETS OF SNAKE VENOMS
RESEARCH SPOTLIGHT
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“FEARED OR LOVED, BUT RARELY UNDERSTOOD 
– VENOMOUS SNAKES ARE FASCINATING FOR 
THE PARADOXICAL ROLE THEY PLAY IN HUMAN 
LIVES: THEY HAVE VENOMS THAT CAN KILL AND 
DESTROY, BUT THE VENOMS ARE ALSO THE 
SOURCE OF BIOACTIVE NATURAL COMPOUNDS 
FROM WHICH NOVEL DRUGS ARE DISCOVERED.” 
- DR TAN CHOO HOCK, VETOX LABORATORY
   Snakebite envenomation remains a neglected tropical disease that imposes a tremendous toll of 
suffering and chronic disability on many poor and marginalized communities. Strategies to overcome this 
global health issue include the improvement of our knowledge on the diversity and complexity of the 
“causative” agents – snake venoms. This relies heavily on fundamental research to unravel the different 
venom properties – the secrets of successful survival of the venomous snakes. 
   Unlocking the secrets of snake venom is, however, not as straightforward as simply cataloging the 
venom components. The genes, the expression patterns and various modification processes of proteins 
ultimately influence the composition, immunogenicity and functions of venoms even though the snakes 
belong to the same species. The variability of snake venom has far-reaching ramification on the clinical 
presentation of snakebite envenomation, and the effectiveness of treatment. The problem is complex and 
challenging, but it fuels the passion of our faculty’s snake venom researchers to delve further into the 
“secrets of snake venom”. The team from the Venom Research and Toxicology Laboratory (VETOX) 
incorporates advanced molecular technologies with various biochemical, immunological and 
pharmacological assays for comprehensive studies of snake venoms. Having investigated more than 30 
snake venoms in the region, the team has established a wealth of snake venom knowledge base essential 
for the elucidation of envenoming pathophysiology and the design of better treatment strategy. Some 
fundamental research findings include the genetic makeup and transcriptomics of our local snakes that 
offer deep insights into the unique sequences and expression of toxins in cobras and pit vipers. Intraspecific 
venom variability has also been unveiled in a number of species, illustrating how toxin molecules, 
immunogenicity and neutralization response to antivenom can diverge.  
   The team also conducts preclinical assessments of different experimental or commercial antivenom 
products, addressing the safety and efficacy issues pertaining to their practical use. The research has left a 
direct positive impact on the choice and use of antivenom in countries like Malaysia and Indonesia. Recently, 
the limiting factor of antivenom efficacy has also been unveiled, thus solving the puzzle of low potency of 
antivenom in neutralizing the venoms and toxins of certain species. It is hoped that the team’s efforts  
will continue to improve snakebite management through the recommendation of a better monitoring system, 
improved treatment protocol and the production of affordable, high quality “broad-spectrum” antivenoms - 
pan-regional, poly-specific products that can be used in different areas for a wider coverage.
   Besides, Vetox Lab is engaged with the 
community through knowledge dissemination and 
information sharing about the science of animal 
venoms and toxins. A series of talks, workshops 
and publications about the scientific basis of 
snakes and venoms are planned for the community 
to better appreciate the impact of snake venoms 
on healthcare and biomedical research. The latest 
aspiration of the team is to venture into the 
discovery of compounds with therapeutic potential 
such as anti-coagulant, anti-cancer and 
anti-inflammatory substances from the precious 
venoms of our local snake species. At present, the 
team has established strong collaboration with 
researchers from local institutes and abroad 
including Thailand, Indonesia, Sri Lanka, India, 
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RESEARCH SPOTLIGHT
MEDICAL BIOTECHNOLOGY LABORATORY 
(MBL) TOWARDS INTERNATIONAL 
RECOGNITION - MS ISO/IEC 17025:2005 
ACCREDITATION
THIBASHINI NAIR, PUTERI SHAFINAZ AKMAR 
& WAN IZLINA IBRAHIM 
MEDICAL BIOTECHNOLOGY LABORATORY (MBL)
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INNOVATION
   The Medical Biotechnology Laboratory (MBL), 
established in 2005 is one of the laboratories under 
the umbrella of Central Research Laboratories 
(CRL), designated as a centralised research facility 
housing the Faculty’s advanced technology and 
basic equipment for conducting research. MBL 
offers proteomics & genomics services and training 
in specialized proteomics & genomics technologies 
within the University of Malaya as well as for other 
local universities and research institutions.
 
   In line with UM’s status as Malaysia's premier 
Research University and one of the leading 
Research Universities in Asia, MBL strives to provide 
excellent service in terms of quality of work, timely 
delivery and professional competency. We started 
our first step in the accreditation journey together 
with 14 other laboratories in UM. MBL’s ISO team, 
headed by Assoc. Prof. Dr. Puteri Shafinaz Akmar 
Abdul Rahman and 5 other team members from 
both MBL and the UM Centre for Proteomics 
Research (UMCPR), underwent continuous 
training, assessment and quality 
improvement for 4 years as part of the 
accreditation process. By going through 
the accreditation processes and regular 
assessments, MBL successfully developed 
a quality management system, increased 
its productivity and raised the technical 
competence of the lab personnel in 
cutting-edge proteomics technology. As 
such, this exercise improved the 
performance, discipline and sense of 
professionalism of the staff. 
   In order to achieve the required high 
quality service performance, to date, MBL 
has braved 8 audits among which are 
Adequacy Audit by SIRIM Sdn. Bhd (30 
September 2015), Pre-assessment Audit by 
SIRIM Sdn. Bhd (19 November 2016) and 
Compliance Audit by Standard Malaysia 
(20 June 2017). Although our journey has 
been a long one, the endeavour has been 
worth the effort. Medical Biotechnology 
Laboratory’s Protein Identification Service
From left to right: Assoc. Prof. Dr Puteri Shaﬁnaz Akmar, Nur Athirah Husin, 
Nosrihah Ismail, Profesor Yvonne Lim,  Jumriah Hiji, Thibashini Nair 
Sathasivan (Not in picture: Dr Jaime Jacqueline Jayapalan)
ALL ABOUT “ARM”: 
AGEING AND REGENERATION MEDICINE RESEARCH THRUST
TAN MAW PIN (DEPARTMENT OF MEDICINE)
THAMIL SELVEE RAMASAMY (DEPARMENT OF MOLECULAR MEDICINE)
THE SCIENCE CAFE
   
The Ageing and Regeneration Medicine (ARM) Research Thrust kicked off the year for 
the Science Café through a display of the collaborative and cross-cutting nature of 
research in this area at the Faculty of Medicine. The year 2018 shows all the promise of 
a research revival at the Faculty with news of substantial research funding from the 
federal budget. After a period of reflection and refinement over recent lean times, we will 
be coming back stronger and better. 
A SCIVAL search revealed that 4166 articles were published in this area in Malaysia since 
2012, of which 1169 (28%) were from the University of Malaya. While the number of 
publications per year has plateaued at just over 700 nationwide and 200 from UM, the 
quality of research has risen convincingly. About 30% of UM publications in ARM topics 
were in the top 10% of most cited publications world-wide in 2017 in comparison to 20% 
of all Malaysian publications. Both UM and Malaysia have improved leaps and bounds 
since 2012 when the figures were a mere 13% and 9% respectively. 
Broadly, research in the ARM thrust fells into four main priority areas: the Ageing 
Process, Degeneration, Stem Cells and Tissue Engineering (SCaTE), and Rehabilitation.
THE PROCESS
Research on process fell within three main themes: Accelerated Ageing, Frailty, and 
Instability. Over the past five years, the Ageing and Age-Associated Disorders (AAAD) 
research group has worked closely with the Centre of Excellence for Research in AIDS 
(CERiA) and several childhood cancer survivor groups to evaluate accelerated ageing. 
The Department of Rehabilitation Medicine also expressed clear ambitions to evaluate 
disability as a model for accelerated ageing. Frailty research saw collaboration between 
AAAD and the Departments of Molecular Medicine and Public Health, while the flag for 
Falls (Instability) research was carried collectively by the Departments of Biomedical 
Imaging, Primary Care, Emergency Medicine, Ophthalmology, Rehabilitation Medicine, 
Cardiology, and Neurology. 
DEGENERATION
Osteoarthritis (OA) research features prominently within the ARM thrust with the 
National Orthopaedics Centre for Excellence for Research and Learning (NOCERAL) 
engaging in biomarker discovery, animal models, and mechanobiology research. In 
addition, cross-cutting collaborations exist between AAAD, Rheumatology, Urology, 
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INFECTIOUS DISEASES AND IMMUNITY RESEARCH THRUST
 REENA RAJASURIA (DEPARTMENT OF PHAMARCOLOGY)
JAMAL I CHING SAM (DEPARTMENT OF MEDICAL MICROBIOLOGY)
THE SCIENCE CAFE
In the second series of the Science Café presentations this year, we heard from 
members of the infectious diseases and immunity research thrust headed by Prof 
Jamal I-Ching Sam. The presentation encompassed projects from members of the 
infectious diseases unit, medical microbiology, immunology and parasitology. Prof 
Jamal highlighted the key strengths of the thrust which included a variety of 
disciplines (ID, microbiology, parasitology, social and preventive medicine, 
pharmacology and entomology) with research projects and expertise covering the 
complete spectrum from bench to bedside. The thrust members also have good 
international links and are supported by reasonable physical infrastructure and 
equipment for research.  One of our biggest strengths is our access to hospital 
patients and community groups which helps make all our work relevant and easily 
translatable into practice. Prof Jamal also spoke about opportunities to study routinely 
collected samples from patients or data mining archived microbiology results 
(isolates/organisms/specimens). 
Dr Reena Rajasuriar worked in the field of translational immunology.  Her research 
interest focused on understanding the pathogenesis of immune activation and 
inflammation in HIV and aging.  She highlighted how it was important to study the 
immune system in tandem with other biological systems (immunology-genetics, 
immunology-metabolomics and immunology-microbiome) to obtain a greater 
appreciation of how the immune system is modulated in health and disease.  
Dr Wong Won Fen’s presentation addressed an intriguing question on how changes in 
Runx1 signalling may alter the activation state of immune cells and their association 
with autoimmune disease. She highlighted a range of techniques used in her studies 
ranging from studies involving knockout mouse to ChIP assays to interrogate the 
function of Runx1. Her other research interests include receptor recognition of 
Helicobacter pylori infections and the role of chronic inflammation by Chlamydia 
trachomatis in infertile females.     
Associate Professor Sharifah Faridah Syed Omar main interests encompass clinical 
and epidemiological studies related to dengue and hepatitis C. Associate Professor 
Iskandar Raja Azwa’s research interests are in HIV clinical research and 
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CANCER AND DRUG DISCOVERY RESEARCH THRUST SERIES 1:
“DRUG DISCOVERY: FROM BENCH TO BEDSIDE”.
TAN CHOO HOCK (DEPARTMENT OF PHARMACOLOGY)
NUR AISHAH MOHD TAIB (DEPARTMENT OF SURGERY)
THE SCIENCE CAFE
The March Science Café was themed “Drug Discovery: From Bench to Bedside”. This 
was the first of three in a series of talks under “Cancer and Drug Discovery Research 
Thrust”, headed by Professor Dr. Nur Aishah Mohd Taib from the Department of 
Surgery, Faculty of Medicine.
The session began with an introduction by Professor Nur Aishah about the 
opportunities, strategies and action plans to strengthen cancer and drug discovery 
research. Following that, Professor Dr. Mohd Rais Mustafa, Head of the Centre for 
Natural Products and Drugs Research (CENAR), shared their research on natural 
compounds that can lead to drugs discovery or green chemistry research. Professor 
Dr. Chung Lip Yong from the Department of Pharmacy and Professor Dr. Misni bin 
Misran (Deputy Dean of Research for the Faculty of Science) from the Department of 
Chemistry subsequently shared with us the use of nanotechnology and chemical 
synthetic technology to improve anti-cancer drug delivert to target sites for greater 
efficacy and less toxicity. 
Dr Thamil Selvee a/p Ramasamy revealed the basis of stem cell biology in cancer 
development which would contribute to a better understanding of cancer cell 
resistance and thus the development of more effective therapeutics. Associate Prof. 
Dr Fung subsequently shared the successes of her team in studying the medicinal 
properties of the tiger milk mushroom, a highly prized medicinal mushroom in 
Malaysia which has various medicinal properties including anti-cancer characteristics.  
Assoc. Prof. Dr Fung Shin Yee from the same department also presented their studies 
on the medicinal properties of the tiger milk mushroom, in particular its anti-cancer 
activity. Following that, Professor Dr. Khalijah Awang from the Department of 
Chemistry, Faculty of Science, shared with us the successes of the Phyto Lab in the 
search for medicinal compounds from a wide variety of natural products in the region. 
From the Department of Surgery, Dr Retnagowri Rajandram highlighted various basic 
research studies including the discovery of biomarkers and targets for anti-cancer 
therapeutics. Ongoing clinical studies and trials on cancer topics were also elaborated 
by Assoc. Prof. Dr. Yoong Boon Koon, consultant from the hepatobiliary surgery team.
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UPCOMING EVENTS
MAY 2018
8 May
Evaluating a Diagnostic or Screening Test in 
the Health Related Sciences with Statistical 
Software Demonstration
9-10 May
Critical Appraisals - RCT and Observational 
Therapeutic Studies Workshop
30-31 May
Hands-on Basic Python Workshop
JUNE 2018
28-29 June
Systematic Review Workshop
JULY 2018
10-11 July
Read papers with Conﬁdence - Critical 
Appraisal: Diagnostic and Prognostic 
Papers Workshop
18-19 July
Hands on Basic Statistics using SPSS
26-27 July
Quantitative Methodology Workshop for 
Health Research
AUGUST 2018
13 August
Hands-on Basic and Advanced REDCap Training
15-16 August
How To Write A Dissertation: Workshop
20 August
E-Procurement Workshop
28-29 August
Managing your References using EndNote
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